Earnings History Data for Exact Sciences Corporation (EXAS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Exact Sciences Corporation

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
02-11-2021 AH 4:05 PM ET
(Nov 2)
EXAS Exact Sciences Corporation 16,640 -0.97 -0.89 -0.36 Exact Sciences EPS misses by $0.12, beats on revenue, updates guidance
[11/2/2021 4:09 PM]
94.28 -1.35 
(-1.42%)
89.07 -6.56 
(-6.86%)
85.82 - 159.54 4,783,206 1,150,000 47,097
28-07-2021 AH 4:00 PM ET
(Jul 28)
EXAS Exact Sciences Corporation 19,460 -1.03 -0.72 -0.58 Exact Sciences EPS misses by $0.27, beats on revenue; Screening revenue guidance lowered
[7/28/2021 4:11 PM]
112.06 -4.00 
(-3.45%)
108.26 -7.80 
(-6.72%)
70.75 - 159.54 2,926,755 1,050,000 60,283
04-05-2021 AH 4:05 PM ET
(May 4)
EXAS Exact Sciences Corporation 22,490 -0.18 -1.04 -0.60 Exact Sciences EPS beats by $0.84, beats on revenue
[5/4/2021 4:04 PM]
110.50 -5.52 
(-4.76%)
117.00 0.98 
(0.84%)
70.75 - 159.54 2,298,548 1,110,000 4,237
16-02-2021 AH 4:05 PM ET
(Feb 16)
EXAS Exact Sciences Corporation 24,750 -0.09 -0.19 -0.37 Exact Sciences EPS misses by $2.59, beats on revenue
[2/16/2021 4:08 PM]
141.33 -12.95 
(-8.40%)
148.01 -6.27 
(-4.06%)
35.25 - 159.54 5,016,457 1,520,088 12,980
27-10-2020 PM 4:05 PM ET
(Oct 29)
EXAS Exact Sciences Corporation 16,473 -0.36 -0.51 0.00 Exact Sciences EPS misses by $0.93, beats on revenue
[10/27/2020 7:13 AM]
131.78 25.21 
(23.66%)
114.00 7.43 
(6.97%)
35.25 - 141.90 18,174,672 1,128,476 495,876
30-07-2020 AH 4:05 PM ET
(Jul 30)
EXAS Exact Sciences Corporation 14,210 -0.58 -0.62 -0.30 EXACT Sciences EPS beats by $0.43, beats on revenue
[7/30/2020 4:22 PM]
93.41 -4.49 
(-4.59%)
97.90 0.0 
(0.00%)
35.25 - 123.31 1,652,971 1,134,399 71,251
06-05-2020 AH EXAS Exact Sciences Corporation 11,580 -0.60 -0.57 -0.66 0.0 0.0 
(0.00%)
0.0 0.0 
(0.00%)
0.0 - 0.0 0 0 0